[HTML][HTML] Advances in the protein‑encoding functions of circular RNAs associated with cancer

W Yuan, X Zhang, H Cong�- Oncology Reports, 2023 - spandidos-publications.com
Circular RNAs (circRNAs) are a special class of non‑coding RNAs that are widely expressed
in tissues and cells. Owing to their lack of a 5'‑cap and 3'‑polyadenylated [poly (A)] tail, they�…

Pyroptosis and inflammasomes in cancer and inflammation

JL Wang, SN Hua, HJ Bao, J Yuan, Y Zhao…�- MedComm, 2023 - Wiley Online Library
Nonprogrammed cell death (NPCD) and programmed cell death (PCD) are two types of cell
death. Cell death is significantly linked to tumor development, medication resistance, cancer�…

Bufalin targeting BFAR inhibits the occurrence and metastasis of gastric cancer through PI3K/AKT/mTOR signal pathway

G Chen, H Zhang, H Sun, X Ding, G Liu, F Yang…�- Apoptosis, 2023 - Springer
Gastric cancer (GC) is the most common malignant tumor of digestive system. Bufalin
extracted from Venenum Bufonis is one of the most effective anticancer monomers, which�…

[HTML][HTML] VPS35 promotes gastric cancer progression through integrin/FAK/SRC signalling-mediated IL-6/STAT3 pathway activation in a YAP-dependent manner

Q Zhou, F Qi, C Zhou, J Ji, J Jiang, C Wang, Q Zhao…�- Oncogene, 2024 - nature.com
VPS35 is a key subunit of the retromer complex responsible for recognising cytosolic
retrieval signals in cargo and is involved in neurodegenerative disease and tumour�…

[HTML][HTML] Cytotoxic activity of Amaryllidaceae plants against cancer cells: biotechnological, in vitro, and in silico approaches

L Trujillo, J Bedoya, N Cort�s, EH Osorio, JC Gallego…�- Molecules, 2023 - mdpi.com
Cancer is a major cause of death and an impediment to increasing life expectancy
worldwide. With the aim of finding new molecules for chemotherapeutic treatment of�…

[HTML][HTML] The Role of Pentraxin 3 in Gastrointestinal Cancers

M Zajkowska, B Mroczko�- Cancers, 2023 - mdpi.com
Simple Summary Gastrointestinal (GI) cancers are all malignant lesions affecting the
esophagus, stomach, liver and intrahepatic bile ducts, gallbladder, pancreas, and small and�…

A predictive nomogram developed and validated for gastric cancer patients with triple-negative tumor markers

Y Xu, P Zhang, Z Luo, G Cen, S Zhang, Y Zhang…�- Future�…, 2024 - Taylor & Francis
Aim: To predict the prognosis of gastric cancer patients with triple-negative tumor markers.
Materials & methods: Prognostic factors of the nomogram were identified through univariate�…

[HTML][HTML] Deficiency of TOP1MT enhances glycolysis through the stimulation of PDK4 expression in gastric cancer

H Wang, X Sun, C Yang, Z Li, D Jin, W Zhu, Z Yu�- Cancer & Metabolism, 2024 - Springer
Background Abnormal glucose metabolism is one of the determinants of maintaining
malignant characteristics of cancer. Targeting cancer metabolism is regarded as a new�…

[HTML][HTML] Immunotherapy of gastric cancer: Present status and future perspectives

JK Triantafillidis, MM Konstadoulakis…�- World Journal of�…, 2024 - ncbi.nlm.nih.gov
In this editorial, we comment on the article entitled “Advances and key focus areas in gastric
cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999�…

[HTML][HTML] LncRNA THUMPD3-AS1 promotes invasion and EMT in gastric cancer by regulating the miR-1297/BCAT1 pathway

Z Zhang, Y Li, L Fan, B Wang, W Liu, J Cui, B Tan�- Iscience, 2023 - cell.com
Long noncoding RNA (lncRNA) plays crucial roles in the development of gastric cancer
(GC); however, studies of their mechanisms of action are needed to determine their clinical�…